Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A two arm pilot study investigating the rate of pathologic complete response in patients with vitamin D deficiency and triple negative breast cancer undergoing standard neoadjuvant chemotherapy + vitamin D supplementation, including an observational arm to describe response in patients who are not deficient. Investigators hypothesize that vitamin D supplementation during neoadjuvant chemotherapy in operable triple negative breast cancer patients with vitamin D deficiency will increase the rate of pathologic complete response chain reaction to that of vitamin D sufficient patients based on historical controls.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza raka piersi potwierdzona badaniem histologicznym
- •Rak piersi typu potrójnie ujemnego (brak receptorów ER, PR i HER2)
- •Pacjent ma być poddany chemioterapii przedoperacyjnej
- •Wiek co najmniej 18 lat
- •Stan ogólny pozwalający na uczestnictwo w badaniu
- •Kobiety w wieku rozrodczym muszą stosować antykoncepcję
- •Zgoda na uczestnictwo w badaniu
✗ Disqualifies
- •Kamienie nerkowe w ostatnim roku
- •Choroba zwana sarcoidozą
- •Podwyższony wapń we krwi (>10,5 mg/dL) w ostatnich 30 dniach
- •Alergia na witaminę D lub podobne substancje
- •Ciąża lub planowana ciąża
- •Karmienie piersią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Wake Forest Baptist Health Sciences
Winston-Salem, United States
Trial contact
Study Coordinator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.